Link Pharma Chem Limited has received an order from the GST Appellate Authority, Tribunal Vadodara dated October 12, 2026. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of SEBI Listing Regulations.

Nature of Order

The GST Appellate Authority has significantly reduced the company's tax liability:

  • Final GST demand reduced from ₹1,32,94,322 to ₹16,29,852 (approximately 88% reduction)
  • Penalty reduced from ₹13,29,433 to ₹2,05,605 (approximately 85% reduction)
  • The order pertains to the tax period 2021-2022

Alleged Violations

The order addresses two specific contraventions:

1. Mismatch between tax liability declared in GSTR1 and tax paid through GSTR3B

2. Excess Input Tax Credit (ITC) availed on import of goods not reflected in GSTR-2A

Financial Impact Assessment

The company states that while the financial impact is limited to the demand, penalty, and interest imposed, there is "no material impact on the company."

Company Response

The company intends to make an appeal with the appropriate authority regarding this order.